Health Canada Archives - World School of Life Sciences IP

Approved Agreement Allowed Validation Concept

Denosumab first interchangeable biosimilars approved by the US FDA

Tanu Goyal April 17, 2024

With the recent approval of the first two interchangeable biosimilars to Amgen’s PROLIA® and XGEVA® by the US FDA in March 2024, the overall count

Maximizing Innovation Lifespans: Canada Patent Term Adjustment

Tanu Goyal August 28, 2023

Maximizing Innovation Lifespans: Canada Patent Term Adjustment To commit to Canada-European Union Comprehensive Economic and Trade Agreement (CETA), Canada introduced Certificate of Supplementary Protection

WSLI

Welcome to World School of Life Sciences IP, a pioneer in empowering minds to dominate the ever-evolving landscape of patents and pharmaceutical innovations.